Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 2
2012 1
2013 2
2014 1
2015 6
2016 2
2018 2
2019 2
2021 3
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Roles of EphA1/A2 and ephrin-A1 in cancer.
Ieguchi K, Maru Y. Ieguchi K, et al. Cancer Sci. 2019 Mar;110(3):841-848. doi: 10.1111/cas.13942. Epub 2019 Feb 15. Cancer Sci. 2019. PMID: 30657619 Free PMC article. Review.
Eph as a target in inflammation.
Ieguchi K. Ieguchi K. Endocr Metab Immune Disord Drug Targets. 2015;15(2):119-28. doi: 10.2174/1871530315666150316121302. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 25772170 Review.
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapy.
Ohkuma R, Fujimoto Y, Ieguchi K, Onishi N, Watanabe M, Takayanagi D, Goshima T, Horiike A, Hamada K, Ariizumi H, Hirasawa Y, Ishiguro T, Suzuki R, Iriguchi N, Tsurui T, Sasaki Y, Homma M, Yamochi T, Yoshimura K, Tsuji M, Kiuchi Y, Kobayashi S, Tsunoda T, Wada S. Ohkuma R, et al. Among authors: ieguchi k. Oncol Lett. 2023 Jul 20;26(3):381. doi: 10.3892/ol.2023.13967. eCollection 2023 Sep. Oncol Lett. 2023. PMID: 37559573 Free PMC article.
Lung Tumor Cell Recruitment Assay.
Tomita T, Ieguchi K, Deguchi A, Takita M, Tsukahara F, Hiratsuka S, Maru Y. Tomita T, et al. Among authors: ieguchi k. J Vis Exp. 2019 Feb 26;(144). doi: 10.3791/53172. J Vis Exp. 2019. PMID: 30882774
Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example.
Maru Y, Tomita T, Deguchi A, Ieguchi K, Takita M, Tsukahara F, Takemura K, Kitao A, Gusovsky F. Maru Y, et al. Among authors: ieguchi k. Endocr Metab Immune Disord Drug Targets. 2015;15(2):83-7. doi: 10.2174/187153031502150522123746. Endocr Metab Immune Disord Drug Targets. 2015. PMID: 26004773 Review.
Novel quantitative immunohistochemical analysis for evaluating PD-L1 expression with phosphor-integrated dots for predicting the efficacy of patients with cancer treated with immune checkpoint inhibitors.
Ohkuma R, Miura S, Muto S, Toyomasu Y, Fujimoto Y, Ieguchi K, Onishi N, Shimizu T, Watanabe M, Takayanagi D, Goshima T, Horiike A, Hamada K, Ariizumi H, Shimokawa M, Hirasawa Y, Ishiguro T, Suzuki R, Iriguchi N, Tsurui T, Mura E, Takenoshita S, Numajiri K, Okabe N, Yoshimura K, Tsuji M, Kiuchi Y, Yajima T, Ishida H, Suzuki H, Yamochi T, Kobayashi S, Tsunoda T, Wada S. Ohkuma R, et al. Among authors: ieguchi k. Front Immunol. 2023 Sep 18;14:1260492. doi: 10.3389/fimmu.2023.1260492. eCollection 2023. Front Immunol. 2023. PMID: 37790929 Free PMC article.
26 results